Document Detail


Cannabinoid derivatives induce cell death in pancreatic MIA PaCa-2 cells via a receptor-independent mechanism.
MedLine Citation:
PMID:  16500647     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Cannabinoids (CBs) are implicated in the control of cell survival in different types of tumors, but little is known about the role of CB system in pancreatic cancer. Herein, we investigated the in vitro antitumor activity of CBs and the potential role of their receptors in human pancreatic cancer cells MIA PaCa-2. Characterization tools used for this study included growth inhibition/cell viability analyses, caspase 3/7 induction, DNA fragmentation, microarray analysis and combination index-isobologram method. Our results demonstrate that CBs produce a significant cytotoxic effect via a receptor-independent mechanism. The CB1 antagonist N-(piperidin-1-1yl)-5-(4-iodophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide (AM251) was the most active compound with an IC50 of 8.6 +/- 1.3 microM after 72 h. AM251 induces apoptosis, causes transcriptional changes of genes in janus kinase/signal transducers and activators of transcription signaling network and synergistically interacts with the pyrimidine analogue, 5-fluorouracil. These findings exclude the involvement of CB receptors in the regulation of MIA PaCa-2 cell growth and put AM251 forward as a candidate for the development of novel compounds worthy to be tested in this type of neoplasia.
Authors:
Stefano Fogli; Paola Nieri; Andrea Chicca; Barbara Adinolfi; Veronica Mariotti; Paola Iacopetti; Maria Cristina Breschi; Silvia Pellegrini
Related Documents :
24942857 - Role of the third intracellular loop in the subtype-specific internalization and recycl...
10188977 - Agonist-inverse agonist characterization at cb1 and cb2 cannabinoid receptors of l75963...
16584117 - Activation of g-proteins in brain by endogenous and exogenous cannabinoids.
10026437 - Mechanism of cholecystokinin-a- receptor antagonist on human pancreatic exocrine secret...
17428227 - G-protein-coupled receptors: an update.
9262197 - Ischemia changes the coexpression of somatostatin and neuropeptide y in hippocampal int...
Publication Detail:
Type:  Journal Article     Date:  2006-02-20
Journal Detail:
Title:  FEBS letters     Volume:  580     ISSN:  0014-5793     ISO Abbreviation:  FEBS Lett.     Publication Date:  2006 Mar 
Date Detail:
Created Date:  2006-03-17     Completed Date:  2006-06-07     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0155157     Medline TA:  FEBS Lett     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  1733-9     Citation Subset:  IM    
Affiliation:
Department of Psychiatry, University of Pisa, Via Bonanno, 6, 56126 Pisa, PI, Italy. s.fogli@med.unipi.it
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antineoplastic Agents / pharmacology
Apoptosis / drug effects*
Cannabinoids / antagonists & inhibitors,  pharmacology*
Cell Line, Tumor
Cell Proliferation / drug effects
Humans
Inhibitory Concentration 50
Pancreatic Neoplasms / drug therapy,  pathology*
Piperidines / pharmacology
Pyrazoles / pharmacology
Receptors, Cannabinoid
Chemical
Reg. No./Substance:
0/AM 251; 0/Antineoplastic Agents; 0/Cannabinoids; 0/Piperidines; 0/Pyrazoles; 0/Receptors, Cannabinoid

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Expression of mouse liver receptor homologue 1 in embryonic stem cells is directed by a novel promot...
Next Document:  Pathogenicity of Salmonella: SopE-mediated membrane ruffling is independent of inositol phosphate si...